Linezolid intradiscal (Persica Pharmaceuticals)

N/A

Report date: 2024/12/04 15:51:18

Base Information

Drug NameLinezolid intradiscal (Persica Pharmaceuticals)
Drug Alias NamePP-353
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandDenmarkUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPersica Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPersica Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A